Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
March 20, 2023
Hutch scientists receive $25M to solve breast cancer metastasis
New collaboration will target dormant tumor cells, keeping them asleep (or killing them) so they won’t spread
Red Light, Green Light: Precise cell targeting with Co-LOCKR
From the Baker, Riddell, and Pun Labs, Cancer Basic Biology, Cancer Consortium
Tip Sheet: Diversity in vaccine clinical trials, behind-the-scenes look at COVID-19 biostats, new cell therapy approved, plus meet ‘Megasphaera hutchinsoni’
Summaries of recent Fred Hutch research findings and other news
What's next for T-cell therapies: Q&A with Dr. Stanley Riddell
After approval of latest cellular therapy for non-Hodgkin lymphoma, the immunologist looks ahead
Dr. Stanley Riddell awarded Burke O'Reilly Family Endowed Chair in Immunotherapy
Inspired by child's life-threatening illness, family's gift funds development of next-gen therapies
Circular tandem repeat protein scaffold binds a variety of functional cargo
From the Bradley (Public Health Sciences Division), Stoddard (Basic Sciences Division), Riddell (Clinical Research Division) and Kaiser Groups (Seattle University Biology)
New CAR T cells with synthetic ankyrin repeats
From the Riddell Laboratory, Clinical Research Division
Targeting metastatic breast cancer with CAR T-cell immunotherapy
$4M 'Breakthrough' award funds collaborative research aimed at destroying dormant disseminated tumor cells
Failed Alzheimer’s drug boosts CAR T-cell therapy
Engineered immune cells get a helping hand in new clinical trial for multiple myeloma patients
New program to fast-track lung cancer research from lab to clinic
Patient-focused science at the heart of $13M National Cancer Institute grant
The New Yorker spotlights Fred Hutch’s pioneering cancer research
‘The Promise and Price of Cellular Therapies’ by Siddhartha Mukherjee traces journey from bone marrow transplantation to immunotherapy
Logic-gated CAR-T cells safely target distant tumor cells
From the Riddell Laboratory, Clinical Research Division
Fred Hutch collaborates with new Allen Institute for Immunology
Multi-collaborator initiative aims to map the immune system in health and disease
“Exciting” but early results in trial of immunotherapy for myeloma
Cancer cells disappeared rapidly in patients with high-risk, treatment-resistant disease
Colette Chaney named ‘2018 Nurse of the Year for Research Advancement’
March of Dimes Washington honors the longtime immunotherapy clinical research nurse
Forbes '30 Under 30' lists Hutch immunotherapy researcher Alex Salter
Grad student on short list of young health care influencers
Stronger and faster is not always better
From the Riddell, Paulovich Labs, Clinical Research Division and Gottardo Lab, Vaccine and Infectious Disease Division.
Dr. Marie Bleakley named Gerdin Family Endowed Chair for Leukemia Research
Pediatric cancer physician-scientist feted at rooftop reception
First in-depth profile of CAR T-cell signals suggests how to improve immunotherapy
A Science Signaling paper reports how two common CAR designs impact T-cell efficacy against cancer in the laboratory
Want to make better T-cell therapies? First, figure out how they work.
New study maps out activities, effects of widely used components in cellular immunotherapies